IP Library Granted Patent US 9,840,536
Granted Patent B2
US 9,840,536 · App. 14/936,258 · Granted Dec 12, 2017

Methods and compositions for the treatment of gastrointestinal disorders

Inventors: Mark G. Currie (Sterling, MA); Shalina Mahajan-Miklos (Standford, CA); Li Jing Sun (New York, NY)
Assignee: Ironwood Pharmaceuticals, Inc.
C07K7/08A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,840,536
App. No.
14/936,258
Granted
Dec 12, 2017
Kind
B2
Abstract

Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Claims (4)

1. A method for treating a patient suffering from constipation-predominant irritable bowel syndrome, the method comprising orally administering to the patient a composition comprising a polypeptide consisting of the amino acid sequence Asn Asp Glu Cys Glu Leu Cys Val Asn Val Ala Cys Thr Gly Cys Leu (SEQ ID NO: 73), wherein one or two amino acids are substituted by the D-isomer of the amino acid.

2. The method of claim 1 , wherein two amino acids are substituted by the D-isomer of the amino acid.

3. A method for treating a patient suffering from constipation, the method comprising orally administering to the patient a composition comprising a polypeptide consisting of the amino acid sequence Asn Asp Glu Cys Glu Leu Cys Val Asn Val Ala Cys Thr Gly Cys Leu (SEQ ID NO: 73), wherein one or two amino acids are substituted by the D-isomer of the amino acid.

4. The method of claim 3 , wherein two amino acids are substituted by the D-isomer of the amino acid.

Assignments (3)
SECURITY INTEREST Recorded May 22, 2023
From: IRONWOOD PHARMACEUTICALS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 063711/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2016
From: CURRIE, MARK G.; MAHAJAM-MIKLOS, SHALINA; SUN, LI JING
To: MICROBIA, INC.
Reel/Frame 038219/0083 →
CHANGE OF NAME Recorded Apr 7, 2016
From: MICROBIA, INC.
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 038379/0327 →
Continuity (8)
Continuation 14024552 · Sep 11, 2013
Continuation 13291526 · Nov 8, 2011
Continuation 12568107 · Sep 28, 2009
Continuation 10868744 · Jun 14, 2004
Provisional Application 60478492 · Jun 13, 2003
Provisional Application 60532361 · Dec 23, 2003
Provisional Application 60571386 · May 14, 2004
Related Publication 20160168201A1 · Jun 16, 2016